Relevance of Phytochemical Taste for Anti-Cancer Activity: A Statistical Inquiry
Open Access
- 12 November 2023
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (22) , 16227
Abstract
Targeting inflammation and the pathways linking inflammation with cancer is an innovative therapeutic strategy. Tastants are potential candidates for this approach, since taste receptors display various biological functions, including anti-inflammatory activity (AIA). The present study aims to explore the power different tastes have to predict a phytochemical’s anti-cancer properties. It also investigates whether anti-inflammatory phytocompounds also have anti-cancer effects, and whether there are tastes that can better predict a phytochemical’s bivalent biological activity. Data from the PlantMolecularTasteDB, containing a total of 1527 phytochemicals, were used. Out of these, only 624 phytocompounds met the inclusion criterion of having 40 hits in a PubMed search, using the name of the phytochemical as the keyword. Among them, 461 phytochemicals were found to possess anti-cancer activity (ACA). The AIA and ACA of phytochemicals were strongly correlated, irrespective of taste/orosensation or chemical class. Bitter taste was positively correlated with ACA, while sweet taste was negatively correlated. Among chemical classes, only flavonoids (which are most frequently bitter) had a positive association with both AIA and ACA, a finding confirming that taste has predictive primacy over chemical class. Therefore, bitter taste receptor agonists and sweet taste receptor antagonists may have a beneficial effect in slowing down the progression of inflammation to cancer.Keywords
This publication has 139 references indexed in Scilit:
- Bladder Cancer Immunotherapy: BCG and BeyondAdvances in Urology, 2012
- Prostaglandin E2 EP receptors as therapeutic targets in breast cancerCancer and Metastasis Reviews, 2011
- Prospective Evaluation of Analgesic Use and Risk of Renal Cell CancerArchives of internal medicine (1960), 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Modulation of inflammatory signaling pathways by phytochemicals in ovarian cancerGenes & Nutrition, 2011
- MiR-210 – micromanager of the hypoxia pathwayTrends in Molecular Medicine, 2010
- Anti-Inflammatory Plant Natural Products for Cancer TherapyPlanta Medica, 2010
- Effects of phenylethyl isothiocyanate and its metabolite on cell-cycle arrest and apoptosis in LNCaP human prostate cancer cellsInternational Journal of Food Sciences and Nutrition, 2010
- CagA+ Helicobacter pylori infection and gastric cancer risk in the EPIC‐EURGAST studyInternational Journal of Cancer, 2006
- Epstein-Barr virus, cytokines, and inflammation: A cocktail for the pathogenesis of Hodgkin's lymphoma?Experimental Hematology, 2006